We are live on ! Find out more
EDSA icon

Edesa Biotech

8 hedge funds and large institutions have $10K invested in Edesa Biotech in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

0.06% less ownership

Funds ownership: 0.07%0.01% (-0.06%)

11% less funds holding

Funds holding: 98 (-1)

93% less capital invested

Capital invested by funds: $145K → $10K (-$135K)

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Braun-Bostich & Associates
Pennsylvania
$7K +$9.17K +446 New
UBS Group
2
UBS Group
Switzerland
$2K +$2.71K +132 +825%
Bank of America
3
Bank of America
North Carolina
$1K +$946 +46 New
Renaissance Technologies
4
Renaissance Technologies
New York
-$103K -3,582 Closed
Deutsche Bank
5
Deutsche Bank
Germany
-$41K -1,430 Closed
Wells Fargo
6
Wells Fargo
California
+$41 +2 New
Osaic Holdings
7
Osaic Holdings
Arizona
+$411 +20 New

EDSA Hedge Fund Activity: Q1 2020 in Review

8 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2020, worth a combined $10K — down 93% from $145K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new EDSA positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Braun-Bostich & Associates, opening a new position worth an estimated $9.17K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $103K sold.

  • 8 institutional investors held Edesa Biotech (EDSA) as of Q1 2020, down from 9 in Q4 2019.
  • Funds reported $10K of Edesa Biotech stock for Q1 2020, down 93% quarter-over-quarter.
  • 4 funds opened new Edesa Biotech positions in Q1 2020 and 3 closed out, a net change of +1 holder.
  • The largest Edesa Biotech buyer in Q1 2020 was Braun-Bostich & Associates, an estimated $9.17K added.
  • The largest Edesa Biotech seller in Q1 2020 was Renaissance Technologies, an estimated $103K sold.

Based on aggregated 13F filings for Q1 2020.